Skip to main content

J&J Assumes Responsibility Of Vaccine Manufacturing At Emergent Facility

Johnson & Johnson announced on Saturday that it is assuming full responsibility regarding the manufacturing of drug substances for its COVID-19 vaccine at the Emergent BioSolutions Bayview facility.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.